Occlutech is a company based in Germany that specializes in minimally invasive heart implants. They operate in the areas of stroke, congenital heart defects, and heart failure, with a focus on developing medical devices for the treatment of structural heart disease. The company has over 16 years of experience in making Nitinol-based cardiac implants and has developed a unique, patented braiding technology for their products. Occlutech's products are sold in over 85 countries. They are currently conducting studies to investigate the safety and efficacy of their products, with a vision to become a specialist in heart implants. The company has a main operation site in Germany and serves 15 direct markets, with a distributor network. They have over 200 patents and have sold more than 146,000 implants. Occlutech aims to get FDA approval for their implants for heart failure and stroke prevention.
Headquarters
Occlutech Blok No:6 Yesilkoy Sb Mahallesi E Blok Sokak Bakirkoy
Istanbul; Marmara;
Postal Code: 34149
Contact Details: Purchase the Occlutech Tibbi Urunler San. Ve Tic. Ltd. Sti. report to view the information.
Website: http://www.occlutech.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service